Buy Hexen for sale online from USA vendor
Discount program: 5% OFF for the second order, 7% OFF for the third order.
Shop with us securely! We offer re-shipment guarantees.
We always provide new, legal products of impeccable quality.
Please make sure that the product is legal in your country and not under any restrictions before ordering.
We do not sell pharmaceutical products or controlled substances.
What is Hexen
N-Ethylhexedrone sometimes referred to as α-ethylaminocaprophenone, N-ethylnorhexedrone, Hexen, and NEH, is a cathinone-class stimulant medication. The potency of this medication as a norepinephrine-dopamine reuptake inhibitor is reported to be 0.0978 and 0.0467 M, respectively. In the 1960s, N-ethylhexedrone was first described in a series of Boehringer Ingelheim patents, which led to the creation of the better-known medication methylenedioxypyrovalerone (MDPV).
Since the mid-2010s, N-ethylhexedrone has been offered online as a designer drug, and in 2018, it was the second most often recognized substance of the cathinone class among DEA seizures. N-ethylhexedrone continues to be used recreationally and has earned a reputation as a designer drug despite its contentious past. This article will examine the history, effects, and risks associated with N-ethylhexedrone.
History of N-Ethylhexedrone
In the 1960s, N-ethylhexedrone was described initially in a series of Boehringer Ingelheim patents. Due to the drug's potency, it was created as a possible medication but has yet to market. However, its research cleared the path for producing the well-known designer drug methylenedioxypyrovalerone (MDPV).
N-ethylhexedrone was found in the middle of the 2010s and began to be offered online as a designer drug. It immediately became one of the most regularly used medications in its class among individuals seeking a high stimulant effect.
Effects of N-Ethylhexedrone
As a norepinephrine-dopamine reuptake inhibitor, N-Ethylhexedrone amplifies the actions of these neurotransmitters in the brain. This can result in euphoric sensations, more incredible energy, and enhanced sociability. Nonetheless, it can also increase anxiety, sleeplessness, and heart rate.
The duration of N-effects ethylhexedrone might range from a few hours to days, depending on dose and person. Some individuals claim to experience effects for up to 12 hours; others report experiencing effects for only a few hours.
Dangers of N-Ethylhexedrone
As with other designer medications, N-ethylhexedrone can be hazardous, and its potency can vary substantially from batch to batch. The medicine induces dangerous adverse effects, including heart palpitations, high blood pressure, and an accelerated heart rate. In addition, it can cause paranoia, anxiety, and sleeplessness.
In addition, N-ethylhexedrone is prohibited in many nations, and its manufacturing and distribution are closely monitored. Consequently, it is frequently offered on uncontrolled marketplaces, and its strength and purity levels can vary substantially. This can result in severe health implications, and consumers are frequently warned to avoid the substance.
To prepare the content, the following materials were used:
- FDA Substance Registration System
- Hazardous Substances Data Bank. National Library of Medicine. 28 August 2008. Retrieved 22 August 2014. 3,4-Methylenedioxymethamphetamine
- Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis. PDF . By HoChong Gilles, Scott C Matherly, Mohammed S Siddiqui, Puneet Puri...
- Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis . By Jasmohan Bajaj
- An overview of alcohol and other drug issues
- Medicating the mind: a Kantian analysis of overprescribing psychoactive drugs B A Manninen
- The pharmacological basis of opioids Carla Ghelardini, Lorenzo Di Cesare Mannelli and Enrica Bianchi
- Ask Dr. Shulgin Online ARCHIVE: June 3, 2004
- Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines. Nicholas V Cozzi, Michael KSievert, Alexander T Shulgin, Peyton JacobIII, Arnold Eruoho
- Schedules of Controlled Substances: Placement of Methylone Into Schedule I
- Bioanalysis of new designer drugs. Wohlfarth A, Weinmann W.
- New Psychoactive Substances (including synthetic cannabinoids, mephedrone, and more)
- Future Synthetic Drugs of Abuse. Donald A. Cooper. Drug Enforcement Administration McLean, Virginia
- Designer drugs: a medicinal chemistry perspective. F. Ivy Carroll Anita H. Lewin S. Wayne Mascarella Herbert H. Seltzman P. Anantha Reddy
- Synthetic cannabinoids in Europe
- Pharmacological Effects of MDMA in Man. By Enno Freye
- Drug Use in Relation to Outcome of Mammography Screening. von Euler-Chelpin M, Wu W, Vejborg and Lynge E
- DEA Drug Scheduling
- Electrophysiological Effects of Trace Amines on Mesencephalic Dopaminergic Neurons.Ada Ledonne, Nicola Berretta, Alessandro Davoli, Giada Ricciardo Rizzo, Giorgio Bernardi and Nicola Biagio Mercuri
- Electrophysiological evidence for a reciprocal interaction between amphetamine and cocaine-related drugs on rat midbrain dopaminergic neurons.Scarponi M, Bernardi G, Mercuri NB.
- Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management. Henry A. Spiller, author Hannah L. Hays Alfred Aleguas.
- Dose-dependent effectiveness of wheel running to attenuate cocaine-seeking: impact of sex and estrous cycle in rats. Peterson AB, Hivick DP, Lynch WJ.r.
- FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
- ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults
- Controlled Substances Act
- The Art of Drug Synthesis (Wiley Series on Drug Synthesis)
- Cannabis: domestic cultivation widespread
- A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics